Medicare Enrolled
Dr. Michael Berte, MD
Urology Physician · Cleveland, OH
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Berte from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Berte?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Berte
Dr. Michael Berte is an urology physician in Cleveland, OH, with 20 years of NPI registration. Based on federal Medicare data, Dr. Berte performed 4,513 Medicare services across 2,414 unique beneficiaries.
Between the years covered by Open Payments, Dr. Berte received a total of $14,208 from 68 pharmaceutical and/or device companies across 664 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Berte is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 9% volume in OH
$14,208 industry payments
Medicare Practice Summary
Medicare Utilization ↗4,513
Medicare services
Top 9% in OH for urology physician
2,414
Unique beneficiaries
$28
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~226 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| BCG treatment for bladder cancer | 1,160 | $2 | $6 |
| Urinalysis with microscopic exam A urine test performed manually that includes examining the sample under a microscope to check for abnormalities. |
594 | $3 | $25 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
544 | $79 | $202 |
| Genetic analysis to identify organisms A laboratory test that uses genetic analysis and an amplified probe technique to identify specific organisms. |
240 | $34 | $92 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
222 | $8 | $15 |
| PSA test (prostate cancer screening) | 214 | $18 | $106 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
203 | $47 | $197 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
189 | $58 | $117 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
188 | $7 | $63 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
155 | $2 | $20 |
| Abdominal X-ray, 1 view An X-ray image of the abdomen taken from a single angle to visualize internal structures. |
97 | $14 | $82 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
90 | $38 | $90 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 78 | $137 | $707 |
| Principal care management for high-risk disease, first 30 minutes This service covers the initial 30 minutes of clinical staff time per calendar month to manage a single high-risk disease. It is directed by a healthcare professional. |
55 | $47 | $177 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
47 | $49 | $700 |
| Limited retroperitoneal ultrasound A focused ultrasound exam of the area behind the abdominal cavity to evaluate specific structures. |
45 | $22 | $139 |
| Chronic care management, additional 20 min/month This service covers an extra 20 minutes of clinical staff time directed by a healthcare professional for managing two or more chronic conditions each calendar month. |
45 | $36 | $163 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
42 | $61 | $125 |
| Bladder instillation of anti-cancer drug A procedure where an anti-cancer medication is introduced directly into the bladder. This method delivers the treatment locally to the bladder tissue. |
33 | $62 | $330 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
31 | $23 | $515 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
29 | $110 | $412 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
24 | $39 | $108 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
24 | $39 | $65 |
| Complex urodynamic pressure flow study A test that measures the pressure of urine flow in the bladder during voiding to evaluate how well the bladder and urethra are functioning. |
22 | $140 | $845 |
| Electronic assessment of bladder emptying A test that uses electronic monitoring to evaluate how well the bladder empties urine. |
20 | $6 | $193 |
| VRE nucleic acid detection test A laboratory test that uses amplified probe techniques to detect vancomycin-resistant Enterococcus (VRE) DNA in a patient sample. |
20 | $34 | $92 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
16 | $87 | $530 |
| CT scan of abdomen and pelvis, without contrast A computed tomography scan that creates detailed images of the abdominal and pelvic organs. The procedure is performed without the use of intravenous contrast dye. |
16 | $70 | $1,214 |
| CT scan of abdomen and pelvis with contrast A CT scan of the abdomen and pelvis using contrast dye before and after administration to visualize internal structures. |
15 | $190 | $1,852 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
15 | $25 | $121 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
14 | $79 | $299 |
| Simple insertion of temporary bladder tube A procedure to place a temporary tube into the bladder. This allows for the drainage of urine from the bladder. |
13 | $42 | $240 |
| Telephone medical discussion, 5-10 minutes A phone conversation with a physician lasting between 5 and 10 minutes to discuss medical matters. |
13 | $33 | $50 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$14,208
Total received (2018-2024)
Avg $2,030/year across 7 years
Top 12% in OH for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
68
Companies
664
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$13,413 (94.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$795 (5.6%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,096
2023
$3,533
2022
$2,166
2021
$1,923
2020
$1,007
2019
$1,828
2018
$2,655
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
PROGENICS PHARMACEUTICALS, INC.
$140
Blue Earth Diagnostics Limited
$138
Bayer Healthcare Pharmaceuticals Inc.
$88
IMMUNITYBIO, INC.
$78
DENTSPLY IH AB
$72
Dendreon Pharmaceuticals LLC
$61
Sumitomo Pharma America, Inc.
$59
Astellas Pharma US Inc
$56
Tolmar, Inc.
$56
Janssen Biotech, Inc.
$50
Tempus AI, Inc
$47
Medtronic, Inc.
$41
Boston Scientific Corporation
$37
ABBVIE INC.
$31
ConvaTec Inc.
$27
Novartis Pharmaceuticals Corporation
$26
Antares Pharma, Inc.
$21
SUN PHARMACEUTICAL INDUSTRIES INC.
$20
Myriad Genetic Laboratories, Inc.
$19
Calyxo, Inc.
$15
Olympus America Inc.
$13
Top 3 companies account for 33.3% of 2024 payments
All-time payments by company (2018-2024) ›
Astellas Pharma US Inc
$1,581
NeoTract Inc.
$1,550
PROCEPT BioRobotics Corporation
$1,470
Coloplast Corp
$803
Antares Pharma, Inc.
$742
Blue Earth Diagnostics Limited
$615
Dendreon Pharmaceuticals LLC
$602
Janssen Biotech, Inc.
$511
Bayer HealthCare Pharmaceuticals Inc.
$464
UROVANT SCIENCES INC
$358
TOLMAR Pharmaceuticals, Inc.
$345
Progenics Pharmaceuticals, Inc.
$326
Teleflex LLC
$308
C. R. Bard, Inc. & Subsidiaries
$281
GENZYME CORPORATION
$281
Amgen Inc.
$262
Sumitomo Pharma America, Inc.
$249
ConvaTec Inc.
$232
Myriad Genetic Laboratories, Inc.
$220
Bayer Healthcare Pharmaceuticals Inc.
$200
Endo Pharmaceuticals Inc.
$196
Tolmar, Inc.
$193
AbbVie Inc.
$149
PROGENICS PHARMACEUTICALS, INC.
$140
Ferring Pharmaceuticals Inc.
$135
PFIZER INC.
$129
Rochester Medical Corporation
$126
COLOPLAST CORP
$120
ABBVIE INC.
$114
AbbVie, Inc.
$112
AstraZeneca Pharmaceuticals LP
$95
DENTSPLY IH AB
$88
Myovant Sciences Inc.
$87
IMMUNITYBIO, INC.
$78
Sun Pharmaceutical Industries Inc.
$74
Clarus Therapeutics Inc.
$73
MEDIVATION FIELD SOLUTIONS LLC
$57
DENTSPLY IH Inc.
$55
Renovia Inc
$52
Boston Scientific Corporation
$52
Merck Sharp & Dohme LLC
$51
Tempus AI, Inc
$47
Avadel Specialty Pharmaceuticals, LLC
$45
Medtronic, Inc.
$41
Mission Pharmacal Company
$41
Zyla Life Sciences
$35
UroGen Pharma, Inc.
$30
Acerus Pharmaceuticals Corporation
$30
Zyla Life Sciences, Inc.
$27
Axonics, Inc.
$26
Novartis Pharmaceuticals Corporation
$26
Medtronic USA, Inc.
$26
Olympus America Inc.
$25
UROGEN PHARMA, INC.
$24
Allergan Inc.
$22
SUN PHARMACEUTICAL INDUSTRIES INC.
$20
Axonics Modulation Technologies, Inc.
$18
ACCORD HEALTHCARE, INC.
$16
Calyxo, Inc.
$15
Laborie Medical Technologies Corp.
$15
Supernus Pharmaceuticals, Inc.
$13
ROCHESTER MEDICAL CORPORATION
$13
Foundation Medicine, Inc.
$13
Photocure Inc
$13
Metuchen Pharmaceuticals
$13
Clovis Oncology, Inc.
$12
Verity Pharmaceuticals Inc.
$12
Allergan, Inc.
$12
Top 3 companies account for 32.4% of all-time payments
Associated products mentioned in payments ›
AMS 700 · ANKTIVA · AQUABEAM ROBOTIC SYSTEM · AVEED · Androgel · AquaBeam Robotic System · Aquoral · Axonics r-SNM System · Axumin · BOTOX · Bard Urinary Drainage Bag · Bulkamid · CAMCEVI · CVAC ASPIRATION SYSTEM · CYSVIEW · ELIGARD · ERLEADA · Erleada · FIRMAGON · FLEXIVA · GEMTESA · GENESIS · GENTLECATH · GENTLECATH GLIDE · Genesis · GentleCath · INTERSTIM · JATENZO · JELMYTO · JEVTANA · KEVZARA · KEYTRUDA · LEXISCAN · LOFRIC · LUPRON DEPOT · LYNPARZA · LoFric · Lupron Depot · MYRBETRIQ · Myrbetriq · NOCDURNA · Natesto · Noctiva · Nubeqa · ORGOVYX · OTREXUP · Otrexup · PENILE & TESTICULAR RECONSTRUCTN · PLUVICTO · POSLUMA · PROLARIS · PROVENGE · PYLARIFY · Prolia · ReTrace · Rubraca · SPEEDICATH · SPRIX · SpeediCath · Stendra · Synthroid · TITAN · TLANDO · Titan · Trelstar · UROLIFT · UroLift · UroLift System · VESICARE · Veozah · XGEVA · XIAFLEX · XTANDI · XYOSTED · Xofigo · Xtandi · YONSA · iTIND System · leva Pelvic Floor Trainer
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (94%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Urology physicians within 10 mi
78
Per 100K population
6.2
County median income
$62,823
Nearest hospital
SOUTHWEST GENERAL HEALTH CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Berte is a clinical cardiology specialist, with above-average Medicare volume (top 9% in OH), with low-engagement industry engagement in the top 12% of OH peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Berte experienced with bcg treatment for bladder cancer?
Based on Medicare claims data, Dr. Berte performed 1,160 bcg treatment for bladder cancer services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Berte receive payments from pharmaceutical companies?
Yes. Dr. Berte received a total of $14,208 from 68 companies across 664 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Berte's costs compare to other urology physicians in Cleveland?
Dr. Berte's average Medicare payment per service is $28. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Berte) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Cleveland
Browse urology physicians in Cleveland ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in OH
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in OH
Which OH urology physicians receive the most from drug and device companies.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
NeoTract Inc. Payments to Doctors
See all physicians who received payments from NeoTract Inc.
By company
PROCEPT BioRobotics Corporation Payments to Doctors
See all physicians who received payments from PROCEPT BioRobotics Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology